Anti-NaPi2b antibody-drug conjugate (ADC), a targeted ADC for SLC34A2, was also proven to be effective and safe in non-small cell lung cancer and ovarian cancer51. The gene discussed is SLC34A2; the disease is non-small cell lung carcinoma.